Histological factors predicting loco-regional lymph node metastasis in early invasive colorectal adenocarcinoma pT1

Kikuchi, 1995, Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines, Dis Colon Rectum, 38, 1286, 10.1007/BF02049154 Ueno, 2004, Risk factors for an adverse outcome in early invasive colorectal carcinoma, Gastroenterology, 127, 385, 10.1053/j.gastro.2004.04.022 Ueno, 2012, New criteria for histologic grading of colorectal cancer, Am J Surg Pathol, 36, 193, 10.1097/PAS.0b013e318235edee Ueno, 2014, Novel risk factor for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review, J Gastroenterol, 49, 1314, 10.1007/s00535-013-0881-3 Barresi, 2012, Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading, Virchows Arch, 461, 621, 10.1007/s00428-012-1326-8 Barresi, 2013, Colorectal carcinoma grading quantified by counting poorly differentiated clusters: is it feasible on endoscopic biopsies?, Am J Surg Pathol, 37, 943, 10.1097/PAS.0b013e31828a69e7 Barresi, 2014, Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer, Virchows Arch, 464, 655, 10.1007/s00428-014-1580-z Barresi, 2014, Histologic grading based on counting poorly differentiated clusters in preoperative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients, Hum Pathol, 45, 268, 10.1016/j.humpath.2013.07.046 Nakadoi, 2012, Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection, J Gastroenterol Hepatol, 27, 1057, 10.1111/j.1440-1746.2011.07041.x Kazama, 2006, Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2, Br J Cancer, 94, 293, 10.1038/sj.bjc.6602927 Nascimbeni, 2002, Risk of lymph node metastasis in T1 carcinoma of the colon and rectum, Dis Colon Rectum, 45, 200, 10.1007/s10350-004-6147-7 Bosch, 2013, Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions, Endoscopy, 45, 827, 10.1055/s-0033-1344238 Beaton, 2013, Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer, Colorectal Dis, 15, 788, 10.1111/codi.12129 Park, 2012, Tumor budding and recurrence in submucosal invasive colorectal cancers of favorable histology: case reports of two early colorectal cancers with advanced recurrences, Korean J Pathol, 46, 272, 10.4132/KoreanJPathol.2012.46.3.272 2009 Prall, 2007, Tumour budding in colorectal carcinoma, Histopathology, 50, 151, 10.1111/j.1365-2559.2006.02551.x Puppa, 2012, Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy, Histopathology, 61, 562, 10.1111/j.1365-2559.2012.04270.x Lugli, 2013, Tumour budding: a promising parameter in colorectal cancer, Br J Cancer, 106, 1713, 10.1038/bjc.2012.127 Chang, 2012, Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review, Ann Surg Oncol, 19, 2477, 10.1245/s10434-012-2303-9 Egashira, 2004, Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer, Mod Pathol, 17, 503, 10.1038/modpathol.3800030 Tateishi, 2010, Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma, Mod Pathol, 23, 1068, 10.1038/modpathol.2010.88 Nishida, 2014, Predictors of lymph node metastasis in T1 colorectal carcinoma: an immunophenotypic analysis of 265 patients, Dis Colon Rectum, 57, 905, 10.1097/DCR.0000000000000168 National Comprehensive Cancer Network, 2012 Van de Velde, 2014, EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum, Eur J Cancer, 50, 1.e1, 10.1016/j.ejca.2013.06.048 Van de Velde, 2013, European Registration of Cancer Care. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe, Eur J Cancer, 49, 2784, 10.1016/j.ejca.2013.04.032 Atkin, 2012, International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition – Colonoscopic surveillance following adenoma removal, Endoscopy, 44, SE151 Vieth, 2012, International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition – Annotations of colorectal lesions, Endoscopy, 44, SE131 Quirke, 2012, International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition – quality assurance in pathology in colorectal cancer screening and diagnosis, Endoscopy, 44, SE116 Quirke, 2011, Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations, Virchows Arch, 458, 1, 10.1007/s00428-010-0977-6 Maurel, 2013, SEOM clinical guidelines for the adjuvant treatment of colorectal cancer 2013, Clin Transl Oncol, 15, 991, 10.1007/s12094-013-1083-4 Watanabe, 2012, Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer, Int J Clin Oncol, 17, 1, 10.1007/s10147-011-0315-2